Study finds GLP-1 drugs keep driving up health insurance spending in Massachusetts
New research points to weight loss drugs as the leading factor behind rising insurance costs in the state.
Recap by typeshit. Post by Facebook on Facebook.
New research points to weight loss drugs as the leading factor behind rising insurance costs in the state.
Recap by typeshit. Post by Facebook on Facebook.
Costco is adding Novo Nordisk's semaglutide shots to what it offers. Details are thin here, so tap through for how pricing and access will work.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Users paying out of pocket spend about $203 a month, and 17% have taken on debt to stay on the drugs, per the Harris Poll survey of over 1,900 adults.
A Face to Face episode covering how the drugs act in the body plus their benefits and risks, with a full replay on YouTube.
Loading…